Healthcare Financing
Singapore pays for healthcare through a layered structure summarised officially as "S+3Ms": government Subsidies first, then MediSave compulsory savings, MediShield Life universal insurance, and MediFund as the endowment-funded safety net of last resort (MOH, accessed Aug 2026; dated financing anchors in healthcare financing anchors). The design intent is that no one is denied appropriate care for inability to pay, while nearly everyone still pays something — a rejection of both fully tax-funded universal healthcare and pure private insurance. In practice a Singaporean's hospital bill is knocked down by subsidy, then charged against insurance, then against their own MediSave balance, with cash covering whatever remains and MediFund available if that cash is genuinely unaffordable.
Government subsidies come first
Before any of the 3Ms apply, MOH subsidies reduce the bill itself at public providers, scaled by ward class and means-tested against household income — deepest in Class C and B2 wards, minimal in B1 and A (MOH, accessed Aug 2026). Subsidies also apply to polyclinic visits, subsidised drugs on the Standard Drug List, and to private GP and dental visits for cardholders under the Community Health Assist Scheme (CHAS). This matters for interpreting the system: descriptions of Singapore as running on "individual savings" understate how much of the underlying cost the state absorbs up front. The savings and insurance layers apply to the already-subsidised remainder, not the sticker price, which is why a heavily subsidised ward stay can be settled entirely from MediSave without touching cash.
MediSave
MediSave is the health component of the CPF system: a compulsory individual savings account, funded by a share of every CPF contribution, that can be spent on the account holder's or their dependants' hospitalisation, day surgery, approved outpatient treatments including chronic disease management, and premiums for MediShield Life and CareShield Life. It is savings, not a subsidy — the money is the member's own, earning the higher CPF interest rate of 4% per annum. Withdrawal limits cap how much may be drawn per day of hospitalisation or per treatment type, which keeps balances from being exhausted early in life. Balances are capped by the Basic Healthcare Sum, set at S$79,000 for members below 65 in 2026, up from S$75,500, and frozen for life at the level applying when a member turns 65; contributions above the cap overflow into other CPF accounts (CPF Board, accessed Aug 2026). Current figures are tracked in annual rates.
MediShield Life
MediShield Life is basic health insurance providing universal, lifelong coverage to all Singapore citizens and permanent residents against large hospital bills and selected costly outpatient treatments such as dialysis and chemotherapy (CPF Board, accessed Aug 2026). Introduced in 2015 to replace the older opt-in MediShield, it is compulsory and cannot be refused: it covers pre-existing conditions and continues regardless of age or health, which was the central reform. Premiums rise with age, are payable from MediSave, and are subsidised for lower- and middle-income households, with additional transitional support. Benefits are pegged to subsidised Class B2/C ward treatment, so it covers such a stay well but leaves large gaps for private or A-ward care — a deliberate design that keeps premiums low. Claims are subject to deductibles and co-insurance, preserving co-payment even within the insurance layer.
Integrated Shield Plans and CareShield Life
MOH describes an Integrated Shield Plan as private insurance that adds coverage above the MediShield Life component, while CPF Board describes CareShield Life as long-term-care insurance paying lifetime cash benefits for severe disability, defined as inability to perform three or more Activities of Daily Living (MOH, accessed Aug 2026; CPF Board, accessed Aug 2026). These schemes address different risks: IPs supplement acute medical-bill coverage, whereas CareShield Life supports prolonged care needs.
Because MediShield Life is calibrated to subsidised wards, most Singaporeans who want private or unsubsidised care buy an Integrated Shield Plan (IP) from a licensed private insurer, which wraps around MediShield Life as a single policy with the additional premium payable partly from MediSave. Roughly two-thirds of residents hold one; tier structure, insurer competition, deductibles, riders, and the 2018 and 2026 co-payment reforms are covered in integrated shield plans. Separately, CareShield Life is compulsory long-term care insurance providing lifelong monthly cash payouts on severe disability, defined as inability to perform at least three activities of daily living; it is universal for younger cohorts and opt-in for older ones, with premiums payable from MediSave. It addresses the gap the 3Ms did not, namely the cost of prolonged care rather than acute episodes (see eldercare).
MediFund and the wider debate
MediFund is an endowment fund whose investment income assists patients who still cannot pay after subsidies, MediShield Life, and MediSave have all been applied; applications are assessed by hospital committees on need, and there are dedicated tranches for the elderly and children (MOH, accessed Aug 2026). Because it is discretionary and endowment-funded rather than an entitlement, it functions as a true backstop rather than a program people plan around. The recurring critiques of the whole structure are that co-payment can deter necessary care among the poor, that the complexity of subsidies, limits, and riders is difficult for patients to navigate, that MediSave balances are inadequate for those with fragmented work histories, and that an individual-savings model handles the concentrated costs of ageing less naturally than risk pooling. Government policy has moved steadily toward more pooling at the edges — MediShield Life's universality, CareShield Life, and subsidy expansions — while holding the co-payment principle at the core.